GETI.B

213.1

+0.47%↑

CAMX

608

-0.08%↓

BIOAB

318.8

-0.25%↓

EKTA.B

56.15

-0.18%↓

AMBEA

141.4

-0.07%↓

GETI.B

213.1

+0.47%↑

CAMX

608

-0.08%↓

BIOAB

318.8

-0.25%↓

EKTA.B

56.15

-0.18%↓

AMBEA

141.4

-0.07%↓

GETI.B

213.1

+0.47%↑

CAMX

608

-0.08%↓

BIOAB

318.8

-0.25%↓

EKTA.B

56.15

-0.18%↓

AMBEA

141.4

-0.07%↓

GETI.B

213.1

+0.47%↑

CAMX

608

-0.08%↓

BIOAB

318.8

-0.25%↓

EKTA.B

56.15

-0.18%↓

AMBEA

141.4

-0.07%↓

GETI.B

213.1

+0.47%↑

CAMX

608

-0.08%↓

BIOAB

318.8

-0.25%↓

EKTA.B

56.15

-0.18%↓

AMBEA

141.4

-0.07%↓

Home・Akcijų sąrašas・Vitrolife AB

V
Vitrolife AB

Uždarymo kaina

138 3.92

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

132.8

Max

139

Pagrindiniai rodikliai
By Trading Economics
Pajamos	-30M 102M
Pardavimai	-36M 835M
P/E Sektoriaus vid.	41.539 76.798
Pelnas, tenkantis vienai akcijai	0.753
Dividendų pajamingumas	0.79
Pelno marža	12.216
Darbuotojai	1,100
EBITDA	118M 255M

Dividendai
By Dow Jones
Dividendų pajamingumas Sektoriaus vid.	0.79% 2.37%
Kitas uždarbis	2026-02-03

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	-1.5B 18B
Ankstesnė atidarymo kaina	134.08
Ankstesnė uždarymo kaina	138

Vitrolife AB Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-12-22 23:54; UTC

Pagrindinės rinkos jėgos

Novo Nordisk ADRs Gain on FDA Approval of First GLP-1 in Pill Form

2025-12-22 19:08; UTC

Įsigijimai, susijungimai, perėmimai

Correction to Alphabet to Buy Intersect Article

2025-12-22 17:21; UTC

Įsigijimai, susijungimai, perėmimai

Alphabet to Buy Intersect for $4.75 Billion as AI-Investment Plans Grow -- Update

2025-12-22 16:46; UTC

Įsigijimai, susijungimai, perėmimai

Alphabet to Buy Intersect for $4.75 Billion in Cash

2025-12-22 23:50; UTC

Rinkos pokalbiai

Nikkei May Decline as Yen Rebounds -- Market Talk

2025-12-22 23:42; UTC

Rinkos pokalbiai

Gold Hits Record High Amid Rising Geopolitical Risks -- Market Talk

2025-12-22 22:31; UTC

Uždarbis

Zhejiang Sanhua Intelligent Controls: Higher Demand for Air-Conditioning Components Supported Results >002050.SZ

2025-12-22 22:31; UTC

Uždarbis

Zhejiang Sanhua Intelligent Controls: Higher Demand for Refrigeration Supported Results >002050.SZ

2025-12-22 22:30; UTC

Uždarbis

Zhejiang Sanhua Intelligent Controls Sees 2025 Net CNY3.87B, Up 25% on Year >002050.SZ

2025-12-22 21:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-12-22 21:50; UTC

Rinkos pokalbiai

Health Care Roundup: Market Talk

2025-12-22 21:37; UTC

Įsigijimai, susijungimai, perėmimai

Capricorn: Project Is Contiguous to Capricorn's Golden Range, Fields Find Tenure

2025-12-22 21:36; UTC

Įsigijimai, susijungimai, perėmimai

Capricorn to Pay A$500,000 Cash, A$4M in New Shares

2025-12-22 21:35; UTC

Įsigijimai, susijungimai, perėmimai

Capricorn to Acquire Prospective Package From Tempest Minerals

2025-12-22 21:35; UTC

Įsigijimai, susijungimai, perėmimai

Capricorn Metals to Buy Yalgoo Project Tenement Package for A$4.5M

2025-12-22 20:54; UTC

Įsigijimai, susijungimai, perėmimai

Middle West Partners Buys Paul Stuart From Mitsui & Co.

2025-12-22 20:52; UTC

Įsigijimai, susijungimai, perėmimai

HCL Technologies: HCLSoftware to Acquire Jaspersoft From Cloud Software Group >532281.BY

2025-12-22 20:09; UTC

Rinkos pokalbiai

U.S. Natural Gas Settles Lower in Choppy Trade -- Market Talk

2025-12-22 19:56; UTC

Rinkos pokalbiai

Crude Gains as U.S. Increases Actions Against Venezuela -- Market Talk

2025-12-22 19:49; UTC

Įsigijimai, susijungimai, perėmimai

A Topsy-Turvy Year for Oracle and the Ellisons Will Bleed into 2026 -- Barrons.com

2025-12-22 19:23; UTC

Rinkos pokalbiai

Mexico's Inflation Seen Easing in Early December -- Market Talk

2025-12-22 19:23; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2025-12-22 19:02; UTC

Rinkos pokalbiai

Global Energy Roundup: Market Talk

2025-12-22 19:02; UTC

Rinkos pokalbiai

Precious Metals Climb to New Heights -- Market Talk

2025-12-22 18:45; UTC

Rinkos pokalbiai

Canadian Trade-Exposed Industries At Forefront of Job Weakness -- Market Talk

2025-12-22 18:30; UTC

Rinkos pokalbiai

Įsigijimai, susijungimai, perėmimai

Intersect Selling Portion of Assets as Part of Alphabet Deal -- Market Talk

2025-12-22 18:23; UTC

Įsigijimai, susijungimai, perėmimai

What Yogi Berra Would Say About the Talks to Take Over Warner Bros. Discovery -- Barrons.com

2025-12-22 17:20; UTC

Rinkos pokalbiai

Health Care Roundup: Market Talk

2025-12-22 17:15; UTC

Rinkos pokalbiai

Global Commodities Roundup: Market Talk

2025-12-22 17:06; UTC

Įsigijimai, susijungimai, perėmimai

Alphabet to Buy Intersect for $4.75B as AI-Investment Plans Grow -- Update

Akcijų palyginimas

Kainos pokytis

Vitrolife AB Prognozė

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę Vitrolife AB

Vitrolife AB (publ) provides assisted reproduction products. It also offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. In addition, the company offers EmbryoScope and time-lapse systems; time-lapse dishes; and evaluation tools for time-lapse systems. The company operates in Europe, the Middle East, India and Africa; Asia; Japan and Pacific; Americas; and Asia. Vitrolife AB (publ) was incorporated in 1989 and is based in Gothenburg, Sweden.